Trial Identifier: | D4326C00004 |
Sponsor: | AstraZeneca |
NCTID:: | NCT06269484 |
Start Date: | February 2024 |
Primary Completion Date: | January 2025 |
Study Completion Date: | January 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
AU | Adelaide, AU, 5000 |
AU | Kogarah, AU, 2217 |
AU | Mitcham, AU, 3132 |
BE | Edegem, BE, 2650 |
BE | Mechelen, BE, 2800 |
CZ | Liberec, CZ, 460 63 |
CZ | Mladá Boleslav, CZ, 293 01 |
CZ | Plzeň, CZ, 323 00 |
CZ | Praha 4, CZ, 140 21 |
DE | Aachen, DE, 52074 |
DE | Kiel, DE, 24146 |
DE | Leipzig, DE, 04103 |
DE | Tuebingen, DE, 72076 |
GB | Aberdeen, GB, AB25 2ZN |
GB | Hull, GB, HU3 2KZ |
GB | Ipswich, GB, IP4 5PD |
GB | London, GB, SE5 9RS |
GB | Nottingham, GB, NG7 2UH |
IT | Milano, IT, 20122 |
IT | Padova, IT, 35128 |
IT | Roma, IT, 00168 |
JP | Gifu-shi, JP, 500-8513 |
JP | Iizuka-shi, JP, 820-8505 |
JP | Kawasaki-shi, JP, 215-0026 |
JP | Kitakyusyu-shi, JP, 806-8501 |
JP | Nagaoka-shi, JP, 940-2085 |
JP | Niigata-shi, JP, 951-8520 |
JP | Sapporo-shi, JP, 006-8555 |
JP | Yokohama-shi, JP, 236-0004 |
PL | Bydgoszcz, PL, 85-794 |
PL | Katowice, PL, 40-081 |
PL | Kraków, PL, 31-513 |
PL | Mysłowice, PL, 41-400 |
PL | Poznań, PL, 61-848 |
PL | Wrocław, PL, 52-210 |
SK | Bratislava, SK, 83104 |
SK | Nitra, SK, 950 01 |
SK | Trnava, SK, 91702 |
US, CO | Englewood, CO, US, 80113 |
US, SC | Charleston, SC, US, 29425 |
US, TX | San Antonio, TX, US, 78215 |